Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2008-01-15
2008-01-15
Tsang, Cecilia J. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
07319088
ABSTRACT:
The invention relates to an antibiotic substance of microbial origin, arbitrarily denominated antibiotic 107891 which is produced by fermentation ofMicrobisporasp. ATCC PTA-5024, the pharmaceutically acceptable salts and compositions thereof, and their use as an antibacterial agent having inhibitory activity versus susceptible microbes. Antibiotic 107891, which is a complex comprising two Factors, denominated Factors A1 and A2, has a peptide structure containing lanthionine and methyllanthionine as constituents which are typical characteristics of the antibiotics of the lantibiotics group. Antibiotic 107891 and its Factors A1 and A2 show a good antibacterial activity against Gram-positive bacteria including methicillin resistant and vancomycin resistant strains, and is active also against some Gram-negative bacteria such asM. catharralis, Neisseriaspecies andH. influenzaeandMycobacteria.
REFERENCES:
patent: 6551591 (2003-04-01), Lee
patent: 6699839 (2004-03-01), Lavoie et al.
patent: 0 592 835 (1994-04-01), None
patent: 59 198982 (1984-11-01), None
patent: WO2005/014628 (2005-02-01), None
Database WPI Section Ch, Week 198451, Derwent Publications Ltd., London, GB, AN 1984-316058.
Hayakawa, M. et al. “Distribution of antibiotic-producingMicrobisporastrains in soils with different pHs” ACTINOMYCETES 6(3): 75-79 (1995).
Lazzarini, A. et al. “Rare-genera of actinomycetes as potential producers of new antibiotics” antonie Van Leeuwenhoek 78(3-4): 399-405 (Dec. 2000).
McAuliffe, O. et al. “Lantibiotics: structure, biosynthesis and mode of action” FEMS Microbiology Reviews 25(3): 285-308 (May 2001).
Sahl, H-G. et al. “Lantibiotics : Biosynthesis and Biological Activities of Uniquely Modified Peptides from Gram-Positive Bacteria” Ann. Rev. Microbiol. 52:41-79 (1998).
Xu, S-Z et al. “Isolation of the genusMicrobisporafrom soil of China” Weishengu Xuebao 19(3): 255-58 (1979).
Candiani Gianpaolo
Ciciliato Ismaela
Gastaldo Luciano
Lazzarini Ameriga
Losi Daniele
Ashbrook Charles W.
Bradley Christina M.
Engelmann John H.
Kappos John
Tsang Cecilia J.
LandOfFree
Antibiotic 107891, its factors A1 and A2, pharmaceutically... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibiotic 107891, its factors A1 and A2, pharmaceutically..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibiotic 107891, its factors A1 and A2, pharmaceutically... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2809820